Rankings
▼
Calendar
FLGT Q2 2025 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena
FLGT
Fulgent Genetics, Inc.
$458M
Q2 2025 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$82M
+15.2% YoY
Gross Profit
$34M
42.1% margin
Operating Income
-$20M
-24.1% margin
Net Income
-$19M
-23.2% margin
EPS (Diluted)
$-0.61
QoQ Revenue Growth
+11.4%
Cash Flow
Operating Cash Flow
-$30M
Free Cash Flow
-$37M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$1.2B
Total Liabilities
$88M
Stockholders' Equity
$1.1B
Cash & Equivalents
$88M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$82M
$71M
+15.2%
Gross Profit
$34M
$26M
+30.0%
Operating Income
-$20M
-$19M
-4.3%
Net Income
-$19M
-$9M
-117.6%
Revenue Segments
Laboratory Services
$82M
100%
Geographic Segments
UNITED STATES
$76M
87%
Non-US
$6M
6%
Other Countries
$3M
4%
CHINA
$2M
3%
← FY 2025
All Quarters
Q3 2025 →